Roy M. Gulick

Columbia University-Weill Cornell Medicine CFAR (CU-WCM CFAR)

National Institute of Allergy and Infectious Diseases · P30

PI · $2.5M · Columbia University Health Sciences

Research Training in Infectious Diseases

National Institute of Allergy and Infectious Diseases · T32

Contact PI · $5.1M · Weill Medical Coll of Cornell Univ

Weill Cornell Medicine - Rutgers New Jersey Medical School Clinical Trials Unit

National Institute of Allergy and Infectious Diseases · UM1

Contact PI · $44.6M · Weill Medical Coll of Cornell Univ

Cornell Clinical Trials Unit

National Institute of Allergy and Infectious Diseases · U01

Contact PI · $6.5M · Weill Medical Coll of Cornell Univ

HIV Adherence Bottle Intervention Trial

Principal investigator · Completed

Weill Medical College of Cornell University

Dolutegravir Plus Lamivudine Dual Therapy in Treatment Naïve HIV-1 Patients

Study chair · Completed · Phase 2

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

Evaluating the Safety and Tolerability of Antiretroviral Drug Regimens Used as Pre-Exposure Prophylaxis to Prevent HIV Infection in At-Risk Men Who Have Sex With Men and in At-Risk Women

Study chair · Completed · Phase 2

National Institute of Allergy and Infectious Diseases (NIAID)

Adding Maraviroc to Antiretroviral Therapy for Suboptimal CD4 T-Cell Recovery Despite Sustained Virologic Suppression

Study chair · Completed

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections